Personalized circulating tumor DNA detection to monitor immunotherapy efficacy and predict outcome in locally advanced or metastatic non‐small cell lung cancer

Personalized circulating tumor DNA detection to monitor immunotherapy efficacy and predict outcome in locally advanced or metastatic non‐small cell lung cancer

Abstract Objective Immune checkpoint inhibitors (ICIs) or combined with chemotherapy exhibit substantial efficacy for the treatment of advanced non‐small cell lung cancer (NSCLC). However, reliable biomarkers that can monitor response to first‐line ICIs ± chemotherapy remain unclear. Methods A total...

Full description

Bibliographic Details
Main Authors: Lei Cheng, Guanghui Gao, Chao Zhao, Haowei Wang, Chao Yao, Hanchuanzhi Yu, Jichen Yao, Feng Li, Lijie Guo, Qijie Jian, Xiaoxia Chen, Xuefei Li, Caicun Zhou
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Cancer Medicine
Subjects:
circulating tumor DNA
immune checkpoint inhibitors
monitoring efficacy
non‐small cell lung cancer
outcome prediction
Online Access:https://doi.org/10.1002/cam4.6108

Internet

https://doi.org/10.1002/cam4.6108

Similar Items